Benzamide,3,5-dibromo-N-(4-bromophenyl)-2-hydroxy- cas no:87-10-5

Synonyms: Salicylanilide,3,4',5-tribromo- (6CI,8CI); 3,4',5-Tribromosalicylanilide;3,5-Dibromo-6-hydroxybenz-p-bromanilide;3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide; 3,5-Dibromosalicylic acidp-bromoanilide; Agramed; NSC 20526; Sherstat TBS; TBS; Temasept II; TemaseptIV; Tempasept II; Tribromsalan; Trisanil; Trisanyl; Tuasal 100; Tuasol; VancideTBS; WR 34912

Identification

NameBenzamide,3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-
CAS87-10-5
SynonymsSalicylanilide,3,4',5-tribromo- (6CI,8CI); 3,4',5-Tribromosalicylanilide;3,5-Dibromo-6-hydroxybenz-p-bromanilide;3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide; 3,5-Dibromosalicylic acidp-bromoanilide; Agramed; NSC 20526; Sherstat TBS; TBS; Temasept II; TemaseptIV; Tempasept II; Tribromsalan; Trisanil; Trisanyl; Tuasal 100; Tuasol; VancideTBS; WR 34912
EINECS(EC#)201-723-6
Molecular FormulaC13H8 Br3 N O2
Molecular Weight449.95

Chemical Properties

refractive index1.57
storage temp0-6°C

Safety Data

Hazard A suspected carcinogen. Use in cosmetics prohibited (FDA).
Safety

Moderately toxic by ingestion. When heated to decomposition it emits very toxic fumes of Br⁻ and NO_x. See also BROMIDES.
Risk Statements:
R22:Harmful if swallowed.
Safety Statements:
S20:When using, do not eat or drink.and smoke.
RTECS: VN8925000

Toxicity

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
rat	LD50	oral	410mg/kg (410mg/kg)		Industrial Medicine and Surgery. Vol. 39, Pg. 56, 1970.
rat	LD50	subcutaneous	1120mg/kg (1120mg/kg)		U.S.S.R. Patent Document. Vol. #0413949,

supplier list

Boc Sciences: Tel:1-631-5046093; Address: 45-16 Ramsey Road, Shirley, NY 11967, USA